Mary‐Anne Trabaud
- Hepatology top 0.5%
- Hepatitis C virus research 21
- Virology top 2%
- HIV Research and Treatment 19
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 17
- HIV/AIDS Research and Interventions 11
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 5
- Epidemiology top 5%
- Hepatitis B Virus Studies 17
- Liver Disease Diagnosis and Treatment 12
- Co-authors
- C. TrépoGeneviève InchauspéFrançoise BerbyHervé LeratPatrice AndréSylvie RuminOlivier VidalinMarian Major
- Journals
- Nucleic Acids Research (1 paper)Journal of Clinical Investigation (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Mary‐Anne Trabaud
52 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 82
- Hepatology 975
- Virology 355
- Infectious Diseases 480
- Epidemiology 860
- Immunology 188
Countries citing papers authored by Mary‐Anne Trabaud
This map shows the geographic impact of Mary‐Anne Trabaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary‐Anne Trabaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary‐Anne Trabaud more than expected).
Fields of papers citing papers by Mary‐Anne Trabaud
This network shows the impact of papers produced by Mary‐Anne Trabaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary‐Anne Trabaud. The network helps show where Mary‐Anne Trabaud may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary‐Anne Trabaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 13 | |
| 4 | 2021 | 47 | |
| 5 | 2018 | 1 | |
| 6 | 2016 | 6 | |
| 7 | 2014 | 6 | |
| 8 | 2012 | 29 | |
| 9 | 2011 | 37 | |
| 10 | 2009 | 37 | |
| 11 | 2009 | 14 | |
| 12 | 2007 | 7 | |
| 13 | 2007 | 12 | |
| 14 | 2007 | 70 | |
| 15 | 2004 | 22 | |
| 16 | 1998 | 23 | |
| 17 | 1998 | 51 | |
| 18 | 1997 | 8 | |
| 19 | 1996 | 7 | |
| 20 | 1996 | 228 |
About Mary‐Anne Trabaud
Mary‐Anne Trabaud is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 55 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (21 papers), HIV Research and Treatment (19 papers), Hepatitis B Virus Studies (17 papers), HIV/AIDS drug development and treatment (17 papers), Liver Disease Diagnosis and Treatment (12 papers), HIV/AIDS Research and Interventions (11 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Hepatology (975 citations), Virology (355 citations) and Infectious Diseases (480 citations). Mary‐Anne Trabaud has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include C. Trépo, Geneviève Inchauspé, Françoise Berby, Hervé Lerat, Patrice André, Sylvie Rumin, Olivier Vidalin, Marian Major, François Habersetzer and Vinca Icard. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.